Cite
Yadav SS, Li J, Stockert JA, et al. Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications. Transl Oncol. 2017;10(3):357-366doi: 10.1016/j.tranon.2017.01.011.
Yadav, S. S., Li, J., Stockert, J. A., Herzog, B., O'Connor, J., Garzon-Manco, L., Parsons, R., Tewari, A. K., & Yadav, K. K. (2017). Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications. Translational oncology, 10(3), 357-366. https://doi.org/10.1016/j.tranon.2017.01.011
Yadav, Shalini S, et al. "Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications." Translational oncology vol. 10,3 (2017): 357-366. doi: https://doi.org/10.1016/j.tranon.2017.01.011
Yadav SS, Li J, Stockert JA, Herzog B, O'Connor J, Garzon-Manco L, Parsons R, Tewari AK, Yadav KK. Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications. Transl Oncol. 2017 Jun;10(3):357-366. doi: 10.1016/j.tranon.2017.01.011. Epub 2017 Mar 24. PMID: 28342996; PMCID: PMC5369368.
Copy
Download .nbib